Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal ropivacaine for postoperative pain after laparoscopic hysterectomy or endometriosis surgery
ACTRN12620001055998Phase 2Not yet recruiting
- Sponsor
- Vanessa Lusink
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postoperative pain comparing Ropivacaine intrapelvic instillation with Normal saline placebo intrapelvic instillation (2 arms). Primary endpoint: VAS pain score. Planned start Nov 2020; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12620001055998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620001055998.